102 related articles for article (PubMed ID: 21851146)
1. Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model.
Steinstraesser L; Hauk J; Al-Benna S; Langer S; Ring A; Kesting M; Sudhoff H; Becerikli M; Käfferlein H; Jacobsen F
Drug Chem Toxicol; 2012 Jan; 35(1):96-103. PubMed ID: 21851146
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic designer host defense peptide suppresses growth of human liposarcoma.
Steinstraesser L; Schubert C; Hauk J; Becerikli M; Stricker I; Koeller M; Hatt H; von Duering M; Shai Y; Steinau HU; Jacobsen F
Int J Cancer; 2011 Jun; 128(12):2994-3004. PubMed ID: 20734391
[TBL] [Abstract][Full Text] [Related]
3. Suppression of soft tissue sarcoma growth by a host defense-like lytic peptide.
Steinstraesser L; Hauk J; Schubert C; Al-Benna S; Stricker I; Hatt H; Shai Y; Steinau HU; Jacobsen F
PLoS One; 2011 Mar; 6(3):e18321. PubMed ID: 21483840
[TBL] [Abstract][Full Text] [Related]
4. A fish antimicrobial peptide, tilapia hepcidin TH2-3, shows potent antitumor activity against human fibrosarcoma cells.
Chen JY; Lin WJ; Lin TL
Peptides; 2009 Sep; 30(9):1636-42. PubMed ID: 19539000
[TBL] [Abstract][Full Text] [Related]
5. Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.
Harati K; Behr B; Wallner C; Daigeler A; Hirsch T; Jacobsen F; Renner M; Harati A; Lehnhardt M; Becerikli M
Mol Med Rep; 2017 Jan; 15(1):103-110. PubMed ID: 27909727
[TBL] [Abstract][Full Text] [Related]
6. Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways.
Lehnhardt M; Klein-Hitpass L; Kuhnen C; Homann HH; Daigeler A; Steinau HU; Roehrs S; Schnoor L; Steinstraesser L; Mueller O
BMC Cancer; 2005 Jul; 5():74. PubMed ID: 16001973
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic activities of host defense peptides.
Al-Benna S; Shai Y; Jacobsen F; Steinstraesser L
Int J Mol Sci; 2011; 12(11):8027-51. PubMed ID: 22174648
[TBL] [Abstract][Full Text] [Related]
8. Epinecidin-1, an antimicrobial peptide from fish (Epinephelus coioides) which has an antitumor effect like lytic peptides in human fibrosarcoma cells.
Lin WJ; Chien YL; Pan CY; Lin TL; Chen JY; Chiu SJ; Hui CF
Peptides; 2009 Feb; 30(2):283-90. PubMed ID: 19007829
[TBL] [Abstract][Full Text] [Related]
9. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.
Stucke-Ring J; Ronnacker J; Brand C; Höltke C; Schliemann C; Kessler T; Schmidt LH; Harrach S; Mantke V; Hintelmann H; Hartmann W; Wardelmann E; Lenz G; Wünsch B; Müller-Tidow C; Mesters RM; Schwöppe C; Berdel WE
Oncotarget; 2016 Dec; 7(50):82458-82472. PubMed ID: 27738341
[TBL] [Abstract][Full Text] [Related]
11. Performance of the comet assay in a high-throughput version.
Stang A; Witte I
Mutat Res; 2009 Apr; 675(1-2):5-10. PubMed ID: 19386240
[TBL] [Abstract][Full Text] [Related]
12. Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane.
Dai Y; Cai X; Shi W; Bi X; Su X; Pan M; Li H; Lin H; Huang W; Qian H
Amino Acids; 2017 Sep; 49(9):1601-1610. PubMed ID: 28664269
[TBL] [Abstract][Full Text] [Related]
13. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
14. Roles of d-Amino Acids on the Bioactivity of Host Defense Peptides.
Li H; Anuwongcharoen N; Malik AA; Prachayasittikul V; Wikberg JE; Nantasenamat C
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27376281
[TBL] [Abstract][Full Text] [Related]
15. Genotoxic and cytotoxic effects of doxorubicin and silymarin on human hepatocellular carcinoma cells.
Yurtcu E; İşeri Ö; Sahin F
Hum Exp Toxicol; 2014 Dec; 33(12):1269-76. PubMed ID: 24677352
[TBL] [Abstract][Full Text] [Related]
16. Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin.
Do N; Weindl G; Grohmann L; Salwiczek M; Koksch B; Korting HC; Schäfer-Korting M
Exp Dermatol; 2014 May; 23(5):326-31. PubMed ID: 24661024
[TBL] [Abstract][Full Text] [Related]
17. Host Defense Peptides and Cancer; Perspectives on Research Design and Outcomes.
Otvos L
Protein Pept Lett; 2017; 24(10):879-886. PubMed ID: 28155618
[TBL] [Abstract][Full Text] [Related]
18. [Host defense peptides and peptidomimetics as new weapons for cancer treatment].
Lapis K
Magy Onkol; 2010 Mar; 54(1):47-58. PubMed ID: 20350868
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma.
Siurala M; Bramante S; Vassilev L; Hirvinen M; Parviainen S; Tähtinen S; Guse K; Cerullo V; Kanerva A; Kipar A; Vähä-Koskela M; Hemminki A
Int J Cancer; 2015 Feb; 136(4):945-54. PubMed ID: 24975392
[TBL] [Abstract][Full Text] [Related]
20. Pro‑apoptotic effects of pycnogenol on HT1080 human fibrosarcoma cells.
Harati K; Slodnik P; Chromik AM; Behr B; Goertz O; Hirsch T; Kapalschinski N; Klein-Hitpass L; Kolbenschlag J; Uhl W; Lehnhardt M; Daigeler A
Int J Oncol; 2015 Apr; 46(4):1629-36. PubMed ID: 25625225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
